Join us as we host our NFXF Fragile X MasterClass™ Genetics of Fragile X, a by professionals for professionals course. Susan Howell, MS, CGC, MBA, and Matthew Walsh, MMSc, CGC, will provide an overview of the genetics of Fragile X. The course will also cover: the inheritance, indications for testing, the potential impact of the premutation and full mutation results, and resources to share with families.

Review Course Agenda: HERE

Event Details

• Date: November 30, 2023
• Time: 3:00 PM ET (2:00 PM CT, 1:00 PM MT, 12 PM PT)
• Duration: 2 hours and 10 minutes
• Cost: $45 (includes $35 fee for CEUs paid directly to NSGC).
• Location: Virtual Live Webinar (Registration is required to attend).
• Registration: https://info.fragilex.org/nfxf-masterclass-genetics-fragile-x

The National Society of Genetic Counselors (NSGC) has authorized National Fragile X Foundation to offer up to 0.2 CEUs or 2 Category 1 contact hours for the activity NFXF MasterClass(tm) – Fragile X Genetics. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor recertification.

Please reach out to the NFXF with any questions at contact@fragilex.org.

Learn More About the Panelists

Susan Howell, MS, CGC, MBA is an Assistant Professor at the University of Colorado School of Medicine, and has worked as the Genetic Counselor for the Denver Fragile X Clinic at Children’s Hospital Colorado since 2008. During her tenure in Colorado, Susan has worked on a multitude of research projects including several industry-sponsored clinical trials of targeted treatments in Fragile X syndrome, the CDC-funded Fragile X Registry, FORWARD, several NIH-funded clinical trials in infants and adolescents with Klinefelter syndrome, and currently an NIH-funded natural history study of prenatally diagnosed babies with sex chromosome aneuploidies. She currently serves as the co-chair of the Colorado Genetic Counseling Educational Symposium as well as a board member for the national X&Y aneuploidy support group, AXYS as well as the National Fragile X Foundation.

Matthew Walsh, MSSc, CGC, is an adjunct instructor at Emory University School of Medicine and is a clinical genetic counselor with the Emory Genetics Clinic. He attended Emory University School of Medicine, where he received a Master of Medical Science in Genetic Counseling. During his training, Matthew studied the health education needs of men who carry an FMR1 premutation and used his findings to create educational materials. Matthew has an interest in neuromuscular and neurodegenerative genetic conditions, including fragile X-associated ataxia/tremor syndrome, Huntington disease, and Duchenne Muscular dystrophy. He currently provides outpatient genetic counseling services to pediatric and adult patients at the Emory Genetics clinic, as well as inpatient services at Children’s Healthcare of Atlanta.

Hilary Rosselot, NFXF Executive Director, Research Facilitation Lead.  Prior to joining the NFXF team, she worked at the Cincinnati Fragile X Research and Treatment Center for over five years. She has experience as a clinical research coordinator across many types of clinical trials and served as the clinical research manager for the Cincinnati program. She earned a bachelor’s in psychology, an MBA, and is a SOCRA-certified clinical research professional (CCRP).